Aspaveli is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia.1
1. Aspaveli (pegcetacoplan) Summary of Product Characteristics 08/2024. 2. Hillmen P et al. N Engl J Med. 2021;384:1028–1037.
